Bridget A Ykoruk

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Bridget A Ykoruk is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in amide hydrolysis, drug design, and drug discovery.

Publications per year

2022–2024

Publications

Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing

Derun Li, David L. Sloman, Abdelghani Achab et al. · Journal of Medicinal Chemistry · 2022 · 19 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

N-nitrosamine impurity risk assessment in pharmaceuticals: Utilizing In vivo mutation relative potency comparison to establish an acceptable intake for NTTP

Mark W. Powley, Zhanna Sobol, George E. Johnson et al. · Regulatory Toxicology and Pharmacology · 2024 · 18 citations · Full text

Pharmacy, Pharmacology, Toxicology +14

1–2 of 2